By 2050, more than 50 percent of the US population will have skin of color. As it stands, skin of color patients are the majority in California, New Mexico, and Texas, and soon will be the majority in Arizona, Nevada, Georgia, New York, and Florida, the Skin of Color Society reports.
Visit Practical Dermatology's website for full article.
A deeper look into the latest dermatologic issues, trends and breakthroughs with leading skin of color experts
Join us for Luncheon Presentations and Roundtable Discussions with the Skin of Color Society Experts
Tuesday, December 13, 2016 The London Hotel, NYC, Regent Park Room 151 West 54th Street New York, NY 10019 12:00 noon -2:00 pm
Private appointments with the Skin of Color Society Experts are also available before and after the Luncheon program.
Skin of Color Society Presentation topics and experts:
Team 1: Skin of Color Health+Beauty Tech Talk - Get the scoop on the hottest derm-related technological breakthroughs, newer treatments, lasers, at-home gadgets, apps, trends, etc., with special emphasis on risks/concerns in skin of color, led by: Dr. Nada Elbuluk and Dr. Babar Rao.
Nada Elbuluk, MD, MSc, FAAD
Assistant Professor of Dermatology at Ronald O. Perelman Department of Dermatology, NYU Medical Center
Babar K. Rao, MD
Founder and Director of Rao Dermatology NY, NJ, CA / Clinical Professor of Dermatology, Rutgers-Robert Wood Johnson Medical School / Clinical Associate Professor, Weill Cornell Medical School
Amy McMichael, MD
Professor & Chair, Department of Dermatology, Wake Forest Baptist Health Medical Center
Andrew F. Alexis, MD, MPH
Chair, Department of Dermatology, Mount Sinai St. Luke’s & Mount Sinai Roosevelt / Associate Professor of Dermatology, Icahn School of Medicine at Mount Sinai
Marta I. Rendon, MD
Founder Skin Care Research, Medical Director, Rendon Center for Dermatology / Clinical Associate Professor, Department of Dermatology, University of Miami School of Medicine
Seemal R. Desai, MD, FAAD
President & Medical Director, Innovative Dermatology / Clinical Assistant Professor of Dermatology, University of Texas Southwestern
Maritza Perez, MD
Director of Cosmetic Dermatology, St. Luke’s Roosevelt Medical Center / Associate Director of Procedural Dermatology, Beth Israel Medical Center / Clinical Professor of Dermatology, Mount Sinai Icahn School of Medicine
Susan C. Taylor, MD
Founding Co-Director, Skin of Color Center, St. Luke’s-Roosevelt Faculty, Perelman School of Medicine
Skin of Color Society Media Day Sponsors
This year’s Skin of Color Society Media Day is made possible thanks to the generosity of the following sponsors, in support of the educational mission of our Society:
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at www.aclaristx.com.
Recommended by more than 25,000 dermatologists worldwide, La Roche-Posay offers a unique range of daily skincare developed with dermatologists for every skin type to complement and enhance their patients’ treatments and to promote good skincare practices at home every day. Started from Europe’s leading center of thermal dermatology, La Roche-Posay develops formulas with its exclusive Selenium-rich water, used at the center since 1905 to treat over 7,500 patients every year for skin disorders thanks to its antioxidant and soothing properties. Visit: www.laroche-posay.us/
Merz Dermatology delivering a better total experience in aesthetics, dermatology and neurosciences. As part of the Merz Pharma Group, our ambition is to become the most admired, trusted and innovative aesthetics and neurotoxin company. By developing products that improve patients’ health and help them to live better, feel better and look better, we will continue to make significant contributions to the well-being of individuals around the world. Merz Dermatology‘s flagship brand, Naftin® (naftifine HCl), remains the #1 topical antifungal brand prescribed by dermatologists and podiatrists in the U.S. Merz Dermatology is an important contributor to the U.S. dermatology space, offering a well-balanced product portfolio that includes the Naftin® (naftifine HCl) family of products, Onmel™ (itraconazole) and Aluvea™ (Urea 39%) Cream. To learn more about Merz Dermatology and their U.S. product portfolio. Visit: www.merzusa.com/dermatology
Nutrafol®, a first-to-market smart-supplement for healthy hair growth, has leveraged recent innovations in biotechnology to help treat hormonal and stress related hair loss. With patent-pending formulas for both female hair loss and male hair loss, Nutrafol® has captured the hearts of key opinion leaders in the medical and salon channels nationwide. Visit: www.nutrafol.com
Procter & Gamble: Through leading brands like Olay, Art of Shaving, and Head & Shoulders, P&G is committed to understanding and improving skin. Almost all of our products touch or impact skin in some way, making our work with dermatologists crucial to so many moments experienced throughout a typical daily routine. In partnership with leading dermatologists, P&G scientists examined racial similarities and differences in both skin aging and gene expression related to sun exposure in the Multi-Decade and Ethnicity (MDE) study to better understand how to meet the needs of people around the world. This understanding leads P&G brands to create products that patients and consumers find effective and enjoyable to use, enabling a higher level of compliance. Visit: www.pg.com
The "Find a Doctor" database ("Doctor Database") is published by the Skin of Color Society ("SOCS") for educational purposes only. It is intended to provide the public with easy access to information on physicians who treat patients with skin of color and who are SOCS members. SOCS requires that any user wishing to access the Doctor Database agree to the following terms and conditions of this Access Agreement.
If you have any questions about this Access Agreement, please let us know. You may send an e-mail to the Society at
This email address is being protected from spambots. You need JavaScript enabled to view it.
You have declined the terms required to access SOCS “Find a Doctor” Database.
If you chose Decline in error, please click here to read and accept the Find a Doctor agreement.
Thank you.
2023
Hyejin Leah Chung, MD
Fractional CO2 Laser versus Fractional Radiofrequency Microneedling for Hidradenitis Suppurativa-Related Atrophic Scars: A Randomized Controlled Rater-Blinded Study
Jennifer Fernandez, MD, RD
Teledermatology in Kenya: An Assessment of Provider Preferences
Nazgol Sadat Haddadi, MD, MPH
The role of Type I IFNs on Keratinocyte's response to Ultraviolet Light B in Photosensitive Skin Diseases
Courtney Johnson, MD, PhD
Single Cell Transcriptomic View of Cancer-Associated Fibroblasts in Early-Stage Mycosis Fungoides
Tasneem Mohammad
Exploring the clinical, spectroscopic, histologic, and immunohistochemical features of post-inflammatory hyperpigmentation using disease specific validated in-vivo models with comparison to ultraviolet b induced skin pigmentation
The 2023 SOCS Research Grants were made possible thanks to the support from Bristol Myers Squibb, L'Oréal and Pfizer.
2022
Jillian Richmond, PhD
Examining Gene and Protein Expression in Clinically Diverse Mycosis Fungoides Samples From Skin of Color Patients
Shawn Shih, MD
The Utility of Topical Oxymetazoline in Preventing Post-filler Ecchymosis in Skin of Color Patients: A Randomized, Double-blind, Split-Face Study
Nkemjika Ugonabo, MD, MPH
Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser Resurfacing vs. Topical Cysteamine Alone in the Treatment of Melasma: A Prospective, Split-Face Cohort Study
The 2022 SOCS Research Grants were made possible thanks to the support from Pfizer.
2021
Courtney Johnson, MD, PhD
Investigating the Molecular Differences of Cutaneous T-Cell Lymphomas in Black Women for Personalized Therapeutic Options
Nayoung Lee, MD
Laser-Assisted Delivery of 5-Fluorouracil versus Triamcinolone in the Treatment of Keloids
The 2021 SOCS Research Grants were made possible thanks to the support from OrthoDermatologics and Pfizer.
2020
Tarannum Jaleel, MD, MHSc
Racial Variation in the Effect of Sex Hormones in Hidradenitis Suppurativa
Maggi Ahmed, MD, MSc
Melanocyte Transplantation Plus Topical JAK Inhibitor or Tacrolimus for Treatment of Vitiligo: A Randomized Comparative Study
2019
Crystal Aguh, MD
Investigating the Role of Metabolic Dysregulation in the Pathogenesis of CCCA
2018
Shawn G. Kwatra, MD
Molecular Basis of Itch in African Americans
2017
Temitayo A. Ogunleye, MD
Molecular Analysis of Central Centrifugal Cicatricial Alopecia
2016
Courtney Bagayoko, MD
Treatment outcomes for patients with Central Centrifugal Cicatricial Alopecia (CCCA)
2015
Giang-Huong Nguyen, MD
MicroRNA Expression Profiling of Acral Melanoma in Asian Population
2014
Steven H. Yang, MD, PhD
Epigenetic Changes in Ethnic Human Skin During Skin Aging
2013
Jenna O’Neil, MD
Genetic Factors in CCCA
2012
Nada Elbuluk MD, MS
Stretch Stimulus on Melanocyte Function and Dyspigmentation in Human Skin in Vivo: A Pilot Study on Striae Distensae
2011
Donald A. Glass, II, MD, PhD
Uncovering the Genetic Causes of Keloid Formation
2010
Ammar Ahmed, MD
A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral Polypodium Leucotomos Extract as an Adjunct to Sunscreen in the Treatment of Melasma
Ginette A. Hinds (Okoye), MD
Improving acne keloidalis nuchae with targeted ultraviolet B treatment: a prospective, randomized, split-scalp comparison study
2009
John E. Harris, MD, PhD
T cells in mouse model of vitiligo
2008
Roopal V. Kundu, MD
Development and Validation of a Vitiligo-specific Quality of Life Instrument (VitiQol)